Associations Between Cerebral Amyloid Angiopathy, Cognitive Impairment, and Depressive Symptoms
Participants with CAA exhibited higher depressive symptoms and worse cognitive performance than controls. Patients with CAA should be screened and treated for depression. However, treating depression is unlikely to substantially improve cognitive function in CAA.
Authors
- Cheryl R. McCreary (ORCID: https://orcid.org/0000-0003-1572-010X)
- Myrlene Gee (ORCID: https://orcid.org/0000-0001-7934-3695)
- Andrew E. Beaudin (ORCID: https://orcid.org/0000-0002-3295-7232)
- Krista Nelles (ORCID: https://orcid.org/0000-0003-4491-5758)
- Eric Edward Smith (ORCID: https://orcid.org/0000-0003-3956-1668)
- Richard Camicioli (ORCID: https://orcid.org/0000-0003-2977-8660)
- Ryan T. Muir (ORCID: https://orcid.org/0000-0002-9349-1069)
- Glen C. Jickling (ORCID: https://orcid.org/0000-0003-3543-0820)
- Nikita Nukala
- Janina Valencia
- Zahinoor Ismail
Institutions
- University of Alberta (CA)
- University of Calgary (CA)
- Sunnybrook Hospital (CA)
- Sunnybrook Research Institute
- Hotchkiss Brain Institute (CA)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70857_102973
- Primary Topic
- Intracerebral and Subarachnoid Hemorrhage Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00